almontasher: رصيف صحافة اليوم الثلاثاء 26 ايار 2026 الثلاثاء 26ايار 2026 مجازر العدو الصهيوني وتهديداته …
أكمل القراءة »Enhertu significantly improved both progression-free
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial in patients with HER2-low metastatic breast cancer First HER2-low metastatic breast cancer Phase III results for AstraZeneca and Daiichi Sankyo’s Enhertu offer potential to redefine how the disease is classified and treated Positive high-level results from the pivotal DESTINY-Breast04 …
أكمل القراءة »
Al Montasher News

